High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder

被引:108
作者
Breunis, MN
Kupka, RW
Nolen, WA
Suppes, T
Denicoff, KD
Leverich, GS
Post, RM
Drexhage, HA
机构
[1] Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands
[2] Altrecht Inst Mental Htlh Care, Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Utrecht, Netherlands
[4] Univ Texas, SW Med Ctr, Dallas, TX 75230 USA
[5] NIMH, Biol Psychiat Branch, Bethesda, MD 20892 USA
关键词
bipolar disorder; T cells; B cells; NK cells; sIL-2R;
D O I
10.1016/S0006-3223(02)01452-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Previously, we found an increased prevalence of thyroid autoantibodies in patients with bipolar disorder. In the present study, we investigated other signs of immune activation in bipolar patients, in particular an activation of the T cell system. Methods: Fluorescence activated cell scanning (FACS) analysis was performed on lymphocytes of 64 outpatients with DSM-IV bipolar disorder using the T cell marker CD3 in combination with the activation markers MHC-class II, CD25, CD69 or CD71. In 34 patients, these assays were repeated after an interval of 2 years. In addition, T cell activation was determined by measuring serum soluble IL-2 receptor (sIL-2R) in 172 bipolar outpatients. Outcomes were compared with a healthy control group. Results: Significantly higher numbers of circulating activated T cells and raised sIL-2R levels were found in euthymic, manic, and depressed bipolar patients when compared with health v controls. In general, these abnormalities were stable over time. Manic patients showed significantly higher levels of sIL-2R in comparison with depressed patients. Conclusions: The T cell system was found to be activated in both symptomatic and euthymic patients with bipolar disorder. The pathophysiological significance of these findings remains to be explored. (C) 2003 Society of Biological Psychiatry.
引用
收藏
页码:157 / 165
页数:9
相关论文
共 52 条
[31]   Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis [J].
Mikova, O ;
Yakimova, R ;
Bosmans, E ;
Kenis, G ;
Maes, M .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 (03) :203-208
[32]   Diagnostic and Statistical Manual of Mental Disorders [J].
Mittal, Vijay A. ;
Walker, Elaine F. .
PSYCHIATRY RESEARCH, 2011, 189 (01) :158-159
[33]   Comparison of the effects of dopaminergic and serotonergic activity in the CNS on the activity of the immune system [J].
Mizruchin, A ;
Gold, I ;
Krasnov, I ;
Livshitz, G ;
Shahin, R ;
Kook, AI .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 101 (02) :201-204
[34]  
Müller N, 2000, ANN NY ACAD SCI, V917, P456
[35]   INVESTIGATIONS OF THE CELLULAR-IMMUNITY DURING DEPRESSION AND THE FREE INTERVAL - EVIDENCE FOR AN IMMUNE ACTIVATION IN AFFECTIVE PSYCHOSIS [J].
MULLER, N ;
HOFSCHUSTER, E ;
ACKENHEIL, M ;
MEMPEL, W ;
ECKSTEIN, R .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1993, 17 (05) :713-730
[36]  
NATELSON BH, 1998, AM J MED, V105, pS4343
[37]   The Stanley Foundation Bipolar Network I. Rationale and methods [J].
Post, RM ;
Nolen, WA ;
Kupka, RW ;
Denicoff, KD ;
Leverich, GS ;
Keck, PE ;
McElroy, SL ;
Rush, AJ ;
Suppes, T ;
Altshuler, LL ;
Frye, MA ;
Grunze, H ;
Walden, J .
BRITISH JOURNAL OF PSYCHIATRY, 2001, 178 :S169-S176
[38]   IMMUNE PARAMETERS IN EUTHYMIC BIPOLAR PATIENTS AND NORMAL VOLUNTEERS [J].
RAPAPORT, MH .
JOURNAL OF AFFECTIVE DISORDERS, 1994, 32 (03) :149-156
[39]   Immune parameters in rapid cycling bipolar patients before and after lithium treatment [J].
Rapaport, MH ;
Guylai, L ;
Whybrow, P .
JOURNAL OF PSYCHIATRIC RESEARCH, 1999, 33 (04) :335-340
[40]   Circulating lymphocyte subsets in major depression and dysthymia with typical or atypical features [J].
Ravindran, AV ;
Griffiths, J ;
Merali, Z ;
Anisman, H .
PSYCHOSOMATIC MEDICINE, 1998, 60 (03) :283-289